Lucknow: KGMU sees first stem cell transplant of blood cancer patient – Times of India
Times of India |
Lucknow: KGMU sees first stem cell transplant of blood cancer patient
Times of India LUCKNOW: A 38-year-old blood cancer patient at King George’s Medical University (KGMU) has become the first such patient at the medical facility to have undergone a successful stem cell transplant from his bone marrow. Undertaken by the clinical … |
|
The Alliance for Regenerative Medicine Releases Complete Agenda for Sixth Annual Cell & Gene Therapy Investor Day
GlobeNewswire (press release) This year’s Cell & Gene Therapy Investor Day is expected to attract more than 350 attendees, including nearly 200 active investors and analysts. With presentations from more than 35 of the sector’s most promising companies, along with panels and … |
Phys.Org |
Novel synthetic biology technique could lead to breakthroughs in disease treatment
Phys.Org This work represents a significant development in synthetic biology, according to Wilson Wong, a biomedical engineering researcher at Boston University who was not involved in this research. Wong focuses on cellular immunotherapy—the use of the body’s … |
|
Speak Up About Immunotherapy’s Side Effects
Curetoday.com Sometimes patients may not report side effects to their health care team, in fear of their oncologist taking them off a drug that could prolong their survival. BY Brielle Urciuoli. PUBLISHED March 28, 2018. Sometimes patients may not report side … |